ClinConnect ClinConnect Logo
Search / Trial NCT06813430

Non-Contact Low-Frequency Ultrasound Vs Standard LaLonde Protocol for Fingertip Injury Wound Healing

Launched by ST. LUKE'S HOSPITAL, PENNSYLVANIA · Feb 5, 2025

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Non Contact Low Frequency Ultrasound Lalonde Protocol Fingertip Amputation

ClinConnect Summary

This clinical trial is studying two different methods of treating fingertip injuries, specifically those involving amputations. The researchers want to find out if a treatment called non-contact low-frequency ultrasound can help wounds heal better compared to a standard method known as the Lalonde protocol. Participants in the study will be randomly assigned to receive either the ultrasound treatment or the standard treatment, and their wound healing will be monitored over a few weeks.

To be eligible for this trial, you must be at least 18 years old and have a recent fingertip amputation without exposed bones or tendons. If you have certain health issues, like vascular disease or infections, or if your injury requires surgery, you may not qualify. If you do participate, you can expect to attend therapy sessions 2-3 times a week, where healthcare professionals will help you with your wound care and measure your progress. This study is currently recruiting participants of all genders, and it aims to provide valuable information on the best ways to help fingertip injuries heal.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Individuals aged 18 years or older with an acute traumatic fingertip amputation without exposed bone or tendons (Allen 1, Tamai level 1; ICD-10 codes S68.5 and S68.6).
  • Exclusion Criteria:
  • Patients less than 18 years old,
  • Injuries involving exposed bone
  • Those with diagnosis of vascular disease
  • Individuals with clinical suspicion or diagnosis of infection
  • Unable to comply with prescribed therapy sessions
  • Patients undergoing primary closure or surgical intervention
  • Patients experiencing subsequent trauma following treatment initiation

About St. Luke's Hospital, Pennsylvania

St. Luke's Hospital in Pennsylvania is a leading healthcare institution committed to advancing medical knowledge and patient care through innovative clinical research. As a prominent sponsor of clinical trials, St. Luke's Hospital focuses on a wide range of therapeutic areas, leveraging its state-of-the-art facilities and a team of experienced healthcare professionals to ensure the highest standards of research integrity and participant safety. With a dedication to improving health outcomes, St. Luke's collaborates with pharmaceutical companies, academic institutions, and healthcare organizations to facilitate groundbreaking studies that contribute to the development of new treatments and therapies.

Locations

Bethlehem, Pennsylvania, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported